✦ LIBER ✦

Selective Progesterone Receptor Modulator Development and Use in the Treatment of Leiomyomata and Endometriosis

✍ Scribed by Chwalisz, Kristof; Perez, Maria Claudia; DeManno, Deborah; Winkel, Craig; Schubert, Gerd; Elger, Walter

Book ID: 121654201
Publisher: Endocrine Society
Year: 2005
Tongue: English
Weight: 890 KB
Volume: 26
Category: Article
ISSN: 0163-769X
DOI: 10.1210/er.2005-0001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of endometriosis with the nove

Treatment of endometriosis with the novel selective progesterone receptor modulator (SPRM) asoprisnil

✍ K. ChwaliszC. Mattia-Goldberg; M. Lee; W. Elger; A. Edmonds 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 211 KB

Effects of the novel selective progester

Effects of the novel selective progesterone receptor modulator (SPRM) asoprisnil on selected hormonal parameters in subjects with leiomyomata

✍ K. Chwalisz; L. Larsen; K. McCrary; A. Edmonds 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 43 KB

The use of progesterone antagonists and

The use of progesterone antagonists and progesterone receptor modulators in contraception

✍ Irving M Spitz; Paul F.A Van Look; Herjan J.T Coelingh Bennink 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Progesterone antagonists and progesteron

Progesterone antagonists and progesterone receptor modulators in the treatment of breast cancer

✍ Jan G.M. Klijn; Buddy Setyono-Han; John A. Foekens 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Progesterone antagonists and progesteron

Progesterone antagonists and progesterone receptor modulators in the treatment of breast cancer

✍ Jan G.M. Klijn; Buddy Setyono-Han; John A. Foekens 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Progesterone antagonists (PAs) (antiprogestins) or progesterone receptor modulators (PRMs) form an interesting category of new hormonal agents in the treatment of breast cancer. In vitro, antiproliferative effects of different PAs are mainly observed in estrogen-stimulated growth of PR-positive tumo

The selective progesterone receptor modu

The selective progesterone receptor modulator CDB4124 inhibits proliferation and induces apoptosis in uterine leiomyoma cells

✍ Xia Luo; Ping Yin; John S. Coon V.; You-Hong Cheng; Ronald D. Wiehle; Serdar E. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 477 KB